ORPHENADRINE CITRATE
- Product NDC
- 61919-507
- 11-digit product format
- 619190507
- Labeler code
- 61919
- Product ID
- 61919-507_9cab5838-6e00-a78d-e053-2995a90a095e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ORPHENADRINE CITRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA040284
- Marketing category
- ANDA
- Marketing start
- 2018-03-26
- Marketing end
- 0000-00-00
- Substance
- ORPHENADRINE CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-507-30 | ORPHENADRINE CITRATE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-507 | ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 2 | Legacy NDC, 1 package rows | 20200122_68520968-23bb-6ae9-e053-2991aa0a773d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-507-30 | 61919050730 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-507-30) | 2018-03-26 | 0000-00-00 | No | No | Current |